Learn why cytotoxicity test failures are common in medical devices and discover systematic approaches to identify root causes ...

Dexcom reports 13% Q4 revenue growth to $1.26B, beating analyst expectations despite mixed analyst ratings and competitive pressures.

The Mansfield, MA-based company is developing the Revivent System to treat left ventricular dysfunction.

Tecan CDMO integrates optics, electronics, and fluidics via a DFX‑driven NPI and deterministic testing to deliver zero‑defect ...

FDA’s clearance of Medtronic’s Stealth Axis surgical system comes on the heels of the company winning a nod for the Hugo ...

This week's Medtech in a Minute highlights adverse events associated with some AI-powered medical devices as well as news from Baxter and Medline.

Medtronic was recently hit with a $382M verdict in a monopoly suit brought by Applied Medical. MD+DI Senior Editor Amanda Pedersen weighs in on the case.

Oura partners with femtech company Mira to integrate hormone testing data with wellness tracking, targeting the booming $60B ...

Edwards Lifesciences reports strong Q4 2025 results with 13.3% sales growth to $1.57B, driven by TAVR and TMTT performance ...

Hurricane Helene might have happened in 2024, but it’s still negatively impacting Baxter International. The natural disaster disrupted Baxter’s North Carolina facility in 2024. As a consequence of ...

Neurent Medical, a company that has created a minimally invasive solution to treat chronic rhinitis, has raised $74 million ...